(European Society of Cardiology) A specially designed antidote to reverse acute, potentially life-threatening anticoagulant-related bleeding worked quickly, and was well-tolerated according to interim results of the ongoing ANNEXA-4 study.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2cbOekO
No comments:
Post a Comment